Step-up versus primary intensive approach to the treatment of interstitial pneumonia associated with dermatomyositis/polymyositis: a retrospective study

References

• Mills ES, Mathews WH. Interstitial pneumonitis in dermatomyosi-tis. J Am Med Assoc 1956;160:1467–70.
   PubMed Web of Science ®Google Scholar
• Marie I, Hatron PY, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B. Pulmonary involvement in polymyositis and in der-matomyositis. J Ftheumatol 1998;25:1336–43.
   Google Scholar
• Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, et al. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Ftheumatol 1999;26:1527–33.
   Google Scholar
• Marie I, Hachulla E, Cherin P, Dominique S, Hatron P, Hellot MF, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002;47:614–22.
   PubMed Web of Science ®Google Scholar
• Schnabel A, Reuter M, Biederer J, Richter C, Gross WL. Intersti-tial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 2003;32: 273–84.
   Google Scholar
• Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Interstitial lung disease, a common manifestation of newly diag-nosed polymyositis and dermatomyositis. Ann Rheum Dis 2004;63: 297–301.
   Google Scholar
• Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK, et al. Interstitial lung disease in patients with polymyositis, dermatomy-ositis and amyopathic dermatomyositis. Ftheumatology (Oxford) 2005;44:1282–6.
   Google Scholar
• Selva-Ocallaghan A, Labrador-Horrillo M, Munoz-Gall X, Martinez-Gomez X, Majo-Masferrer J, Solans-Laque R, et al. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus 2005;14:534–42.
   PubMedGoogle Scholar
• Arsura EL, Greenberg AS. Adverse impact of interstitial pulmo-nary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 1988;18:29–37.
   PubMed Web of Science ®Google Scholar
• Schwarz MI, Matthay RA, Sahn SA, Stanford RE, Marmorstein BL, Scheinhorn DJ. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 1976;55: 89–104.
   Google Scholar
• Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M, et al. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Ftheu-matol 2005;32:58–64.
   Google Scholar
• Nagasaka K, Harigai M, Tateishi M, Hara M, Yoshizawa Y, Koike T, et al. Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis. Modern Ftheumatol 2003;13:231–8.
   PubMedGoogle Scholar
• Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344–7.
   PubMed Web of Science ®Google Scholar
• Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403–7.
   PubMed Web of Science ®Google Scholar
• King TE, Jr., Safrin S, Starko KM, Brown KK, Noble PW, Raghu G, et al. Analyses of efficacy end points in a controlled trial of in-terferon-gammalb for idiopathic pulmonary fibrosis. Chest 2005; 127:171–7.
   PubMed Web of Science ®Google Scholar
• Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 2002;20: 387–408.
   PubMed Web of Science ®Google Scholar
• Rowen AJ, Reichel J. Dermatomyositis with lung involvement, successfully treated with azathioprine. Respiration 1983;44:143–6.
   PubMed Web of Science ®Google Scholar
• Plowman PN, Stableforth DE. Dermatomyositis with fibrosing al-veolitis: response to treatment with cyclophosphamide. Proc R Soc Med 1977;70:738–40.
   PubMedGoogle Scholar
• al Janadi M, Smith CD, Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Ftheumatol 1989;16:1592–6.
   Google Scholar
• Maccioni FJ, Colebatch HJ. Management of fibrosing alveolitis with polymyositis dermatomyositis. Aust N Z J Med 1990;20: 806–10.
   PubMedGoogle Scholar
• Schnabel A, Reuter M, Gross WL. Intravenous pulse cyclophos-phamide in the treatment of interstitial lung disease due to colla-gen vascular diseases. Arthritis Rheum 1998;41:1215–20.
   Google Scholar
• Sauty A, Rochat T, Schoch OD, Hamacher J, Kurt AM, Dayer JM, et al. Pulmonary fibrosis with predominant CD8 lymphocytic al-veolitis and anti-Jo-1 antibodies. Eur Respir J 1997;10:2907–12.
   PubMed Web of Science ®Google Scholar
• Kourakata H, Takada T, Suzuki E, Enomoto K, Saito I, Taguchi Y, et al. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia. Respirology 1999;4:223–8.
   PubMedGoogle Scholar
• Yamadori I, Fujita J, Kajitani H, Bandoh S, Tokuda M, Ohtsuki Y, et al. Lymphocyte subsets in lung tissues of interstitial pneumo-nia associated with untreated polymyositis/dermatomyositis. Ftheumatol Int 2001;21:89–93.
   PubMed Web of Science ®Google Scholar
• Kurasawa K, Nawata Y, Takabayashi K, Kumano K, Kita Y, Takiguchi Y, et al. Activation of pulmonary T cells in corticoster-oid-resistant and -sensitive interstitial pneumonitis in dermatomy-ositis/polymyositis. Clin Exp Immunol 2002;129:541–8.
   PubMed Web of Science ®Google Scholar
• Gruhn WB, Diaz-Buxo JA. Cyclosporine treatment of steroid re-sistant interstitial pneumonitis associated with dermatomyositis/ polymyositis. J Ftheumatol 1987;14:1045–7.
   Google Scholar
• Maeda K, Kimura R, Komuta K, Igarashi T. Cyclosporine treat-ment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis? Scand J Ftheuma-tol 1997;26:24–9.
   PubMed Web of Science ®Google Scholar
• Dumont FJ. FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem 2000;7:731–48.
   PubMed Web of Science ®Google Scholar
• Ochiai T, Nakajima K, Sakamoto K, Nagata M, Gunji Y, Asano T, et al. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine. Transplant Proc 1989;21:829–32.
   PubMed Web of Science ®Google Scholar
• Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV. Treat-ment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 2005;52:2439–46.
   Google Scholar
• Ochi S, Nanki T, Takada K, Suzuki F, Komano Y, Kubota T, et al. Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomy-ositis. Chin Exp Ftheumatol 2005;23:707–10.
   PubMed Web of Science ®Google Scholar
• Takada K, Nagasaka K, Miyasaka N. Polymyositis/dermatomyo-sitis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunity 2005;38: 383–92.
   Google Scholar